Q-Line Biotech Limited IPO

Q-Line Biotech Limited is listed in the SME segment with a price band of ₹326 to ₹343. The figures below are as reported by the exchanges and public sources.

Q-Line Biotech Limited IPO — key facts

• The Q-Line Biotech Limited IPO price band is ₹326 to ₹343 per share.
• As of 5 September 2026, the Q-Line Biotech Limited IPO subscription status is 102.42x overall.
• The issue is open from 21-MAY-2026 to 25-MAY-2026.
• Q-Line Biotech Limited listed on 29-MAY-2026.
• Q-Line Biotech Limited listed at ₹474.6. The listing gain was 38.4% against the upper end of the issue price band.

Q-Line Biotech Limited IPO details

Status

Listed

Segment

SME

Sector

Medical Equipment & Supplies

Price band

₹326 – ₹343

Issue size

₹203.74 Cr

Fresh issue

₹203.74 Cr

Opens

21-MAY-2026

Closes

25-MAY-2026

Listing

29-MAY-2026

Total subscription

102.42x

Retail

71.44x

QIB

123.94x

NII

145.98x

Lead managers

Hem Securities (left lead)

Listing price

₹474.6

Listing day change

+38.4%

Other Medical Equipment & Supplies IPOs

• Molbio Diagnostics Limited +28.4% on listing
• Avience Biomedicals Limited +99.5% on listing
• QMS Medical Allied Services Limited +11.1% on listing
• Earkart Ltd. +5.4% on listing
• Galaxy Medicare Limited -5.0% on listing
• Laxmi Dental Limited +28.7% on listing

Live subscription, allotment status, offer documents and the full lifecycle timeline for this issue are on this page. Historical listing performance for every past IPO is in the IPO database, and each day's activity is recorded in the daily digest.

Published by INVESTOLOGY — SEBI Registered Research Analyst INH000015297. Data is reported for information only. It is not research and not investment advice. Investments in securities markets are subject to market risk; read all offer documents carefully before investing.